A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

What is it? A medication called semaglutide, which is sold under different brand names, including Ozempic, approved in 2017 for treating type 2 diabetes, and Wegovy, approved just last year for ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Semaglutide Market Size, Share & Trends Analysis Report by Product (Ozempic, Wegovy, Rybelsus), Application (Type 2 Diabetes Mellitus, Obesity), Route ...

1 The first phase, to start in early 2026, will focus on developing a community based service where patients can access lifestyle support and weight loss drugs including semaglutide (Wegovy, Rybelsus) ...

In a head-to-head diet-induced obese (DIO) mouse model, low dose ASC47 in combination with semaglutide demonstrated a 56.7% greater reduction in body weight with muscle preservation compared to ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill from Eli Lilly could be as effective for weight loss and blood sugar ...

Wegovy is the brand name for a form of semaglutide that has since been approved for weight loss. Semaglutide, which mimics a natural hormone called GLP-1, helps regulate blood sugar while slowing ...

Credit: Getty Images Until semaglutide, weight loss of 15% to avoid obesity-related complications was only achieved through bariatric surgery. In clinical trials, semaglutide proved to be superior to ...